Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials von Sullivan, James C., De Meyer, Sandra, Bartels, Doug J., Dierynck, Inge, Zhang, Eileen Z., Spanks, Joan, Tigges, Ann M., Ghys, Anne, Dorrian, Jennifer, Adda, Nathalie, Martin, Emily C., Beumont, Maria, Jacobson, Ira M., Sherman, Kenneth E., Zeuzem, Stefan, Picchio, Gaston, Kieffer, Tara L.

Volltext

Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials von Kieffer, Tara L, De Meyer, Sandra, Bartels, Doug J, Sullivan, James C, Zhang, Eileen Z, Tigges, Ann, Dierynck, Inge, Spanks, Joan, Dorrian, Jennifer, Jiang, Min, Adiwijaya, Bambang, Ghys, Anne, Beumont, Maria, Kauffman, Robert S, Adda, Nathalie, Jacobson, Ira M, Sherman, Kenneth E, Zeuzem, Stefan, Kwong, Ann D, Picchio, Gaston

Volltext

Modeling viral evolutionary dynamics after telaprevir-based treatment von Haseltine, Eric L, De Meyer, Sandra, Dierynck, Inge, Bartels, Doug J, Ghys, Anne, Davis, Andrew, Zhang, Eileen Z, Tigges, Ann M, Spanks, Joan, Picchio, Gaston, Kieffer, Tara L, Sullivan, James C

Volltext

Genotypic and phenotypic analyses of hepatitis C virus variants observed in clinical studies of VX-222, a nonnucleoside NS5B polymerase inhibitor von Jiang, Min, Zhang, Eileen Z, Ardzinski, Andrzej, Tigges, Ann, Davis, Andrew, Sullivan, James C, Nelson, Michelle, Spanks, Joan, Dorrian, Jennifer, Nicolas, Olivier, Bartels, Doug J, Rao, B Govinda, Rijnbrand, Rene, Kieffer, Tara L

Volltext

Modeling Viral Evolutionary Dynamics after Telaprevir-Based Treatment: e1003772 von Haseltine, Eric L, Meyer, Sandra De, Dierynck, Inge, Bartels, Doug J, Ghys, Anne, Davis, Andrew, Zhang, Eileen Z, Tigges, Ann M, Spanks, Joan, Picchio, Gaston, Kieffer, Tara L, Sullivan, James C

Volltext

Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials

Volltext bestellen